- Weitere Titel
-
Die anti-inflammatorische Therapie der Atherosklerose mit Colchicin
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Dissertation, 2023
- Schlagwort
-
Arteriosklerose
Tiermodell
Entzündung
Plaque
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2023
- Urheber
-
Meyer-Lindemann, Clara Ulrike
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bvb:91-diss-20230711-1698445-1-7
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Meyer-Lindemann, Clara Ulrike
- Sager, Hendrik
- Mägdefessel, Lars
- Universitätsbibliothek der TU München
Entstanden
- 2023
Ähnliche Objekte (12)
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
Targeting the chemokine network in atherosclerosis
Linking inflammation and atherosclerosis – novel mechanistic insights into how vascular inflammation fuels progression of atherosclerosis –
Mechanisms of vascular inflammation in atherosclerosis in renal impairment
P2X4 deficiency reduces atherosclerosis and plaque inflammation in mice
Role of serotonin and antidepressants targeting serotonin transporters in atherosclerosis
GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis
New insights into the role of iron in inflammation and atherosclerosis
Targeting cholesterol crystals in atherosclerosis with cholesterol solubilizing 2-hydroxypropyl-beta-cyclodextrin
Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis
The role of tumor necrosis factor associated factors (TRAFs) in vascular inflammation and atherosclerosis
Primate atherosclerosis
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
Targeting the chemokine network in atherosclerosis
Linking inflammation and atherosclerosis – novel mechanistic insights into how vascular inflammation fuels progression of atherosclerosis –
Mechanisms of vascular inflammation in atherosclerosis in renal impairment
P2X4 deficiency reduces atherosclerosis and plaque inflammation in mice
Role of serotonin and antidepressants targeting serotonin transporters in atherosclerosis
GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis
New insights into the role of iron in inflammation and atherosclerosis
Targeting cholesterol crystals in atherosclerosis with cholesterol solubilizing 2-hydroxypropyl-beta-cyclodextrin
Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis
The role of tumor necrosis factor associated factors (TRAFs) in vascular inflammation and atherosclerosis
Primate atherosclerosis
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
Targeting the chemokine network in atherosclerosis
Linking inflammation and atherosclerosis – novel mechanistic insights into how vascular inflammation fuels progression of atherosclerosis –
Mechanisms of vascular inflammation in atherosclerosis in renal impairment
P2X4 deficiency reduces atherosclerosis and plaque inflammation in mice
Role of serotonin and antidepressants targeting serotonin transporters in atherosclerosis
GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis
New insights into the role of iron in inflammation and atherosclerosis
Targeting cholesterol crystals in atherosclerosis with cholesterol solubilizing 2-hydroxypropyl-beta-cyclodextrin
Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis
The role of tumor necrosis factor associated factors (TRAFs) in vascular inflammation and atherosclerosis